Using Mobile Phones to Improve Adherence to Inhaled Steroids

Rush University Medical Center12 enrolled

Overview

This study has two main goals. The first goal is to test whether a mobile phone intervention can increase adherence to daily inhaled steroid medications in African American adolescents prescribed this type of medication by his/her asthma doctor. The second goal is to use a mobile phone intervention to better understand real life patterns of use of quick-relief (beta2-adrenergic agonist) asthma medication in this population.

Study Type

INTERVENTIONAL

Allocation

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

Conditions

Asthma

Interventions

Asthma SupervisionBEHAVIORAL

Each participant will be provided with a spacer and a peak flow meter, and instructions on proper technique, by a member of the study team during the baseline period. They will also meet with study staff at study visits during the active treatment phase to review their adherence to daily inhaled corticosteroids and usage patterns of short acting B2-agonist medication.

Mobile PhoneBEHAVIORAL

Each participant will receive a mobile phone with talking, texting and a data plan. They will get to keep the mobile phone at the end of the study, but the talking, texting and data plan will only be active during their participation in the study.

Inhaled Corticosteroid Mobile Phone ApplicationBEHAVIORAL

Eligibility

Sex: ALLMin age: 11 YearsMax age: 16 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 11-16 years of age * self-identify as African American * have persistent asthma * be on a prescription daily inhaled corticosteroid medication for asthma * be on a prescription inhaled beta2-adrenergic agonist medication for asthma Exclusion Criteria: * candidate refusal * the presence of other co-morbidities that could interfere wtih study participation * \> 60% adherence to inhaled corticosteroid medication, measured by the electronic dose counter, during the run-in period

Locations (1)

Rush University Medical Center

Chicago, Illinois, United States

Outcomes

Primary Outcomes

Adherence to inhaled corticosteroids, measured objectively using an electronic dose counter

Adherence is measured as the mean of daily adherence to prescription inhaled corticosteroid dose over 14 days both at baseline and at week 10 of the active treatment phase. For the primary outcome, we will compare adherence at week 10 to adherence at baseline.

Time frame: 10 weeks

Secondary Outcomes

To understand patterns of use of quick-relief medication for asthma

This study will use an electronic dose counter and mobile phone technology to track participants real time use of quick-relief (beta2-adrenergic agonist) medication for asthma during the 10 weeks of active treatment.

Time frame: 10 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.